Representative Jefferson Shreve (R-Indiana) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $15,001 and $50,000 in UnitedHealth Group stock on April 7th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account.
Representative Jefferson Shreve also recently made the following trade(s):
- Purchased $50,001 – $100,000 in shares of Chipotle Mexican Grill (NYSE:CMG) on 4/17/2025.
- Purchased $50,001 – $100,000 in shares of Applied Materials (NASDAQ:AMAT) on 4/17/2025.
- Purchased $15,001 – $50,000 in shares of Caterpillar (NYSE:CAT) on 4/17/2025.
- Sold $15,001 – $50,000 in shares of Lululemon Athletica (NASDAQ:LULU) on 4/17/2025.
- Purchased $15,001 – $50,000 in shares of Western Digital (NASDAQ:WDC) on 4/17/2025.
- Sold $15,001 – $50,000 in shares of Zoetis (NYSE:ZTS) on 4/17/2025.
- Purchased $15,001 – $50,000 in shares of Stryker (NYSE:SYK) on 4/17/2025.
- Purchased $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 4/17/2025.
- Purchased $15,001 – $50,000 in shares of CSX (NASDAQ:CSX) on 4/17/2025.
- Purchased $15,001 – $50,000 in shares of Ross Stores (NASDAQ:ROST) on 4/17/2025.
UnitedHealth Group Stock Performance
NYSE:UNH traded down $0.61 during trading hours on Monday, reaching $380.03. The company had a trading volume of 3,925,907 shares, compared to its average volume of 4,714,388. The firm has a market cap of $344.74 billion, a price-to-earnings ratio of 24.52, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52 week low of $377.77 and a 52 week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average price is $488.01 and its 200-day moving average price is $522.04.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 35.18%.
Institutional Investors Weigh In On UnitedHealth Group
A number of hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Geode Capital Management LLC boosted its position in UnitedHealth Group by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock valued at $10,068,869,000 after buying an additional 319,515 shares during the last quarter. Capital International Investors increased its stake in shares of UnitedHealth Group by 6.2% in the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after buying an additional 906,365 shares during the last quarter. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. Finally, Northern Trust Corp boosted its holdings in shares of UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
UNH has been the subject of several research analyst reports. KeyCorp cut their target price on UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Oppenheimer decreased their price target on UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating for the company in a report on Monday, April 21st. Robert W. Baird decreased their price target on shares of UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 29th. Finally, Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Four investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $596.86.
View Our Latest Stock Analysis on UnitedHealth Group
About Representative Shreve
Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana’s 6th Congressional District. He declared candidacy for the 2026 election.
Email [email protected] to notify us of updates to this biography.
Jefferson Shreve earned a bachelor’s degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve’s career experience includes working as a real estate executive.
Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- What does consumer price index measure?
- Tech Bears Should Jump on These 3 Inverse ETFs
- Financial Services Stocks Investing
- 5 Reasons the Rebound in Microchip Technology Stock Is Real
- Investing in Commodities: What Are They? How to Invest in Them
- Rocket Lab: Earnings Miss But Neutron Momentum Holds
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.